The role of the glucocorticoid-dependent mechanism in the progression of sodium taurocholate-induced acute pancreatitis in the rat

Pancreas

Volumn 29, Issue 1, 2004, Pages 75-82

  Paszt, Attila ^a   Takacs T ^b   Rakonczay, Z ^b   Kaszaki, J ^a   Wolfard, A ^a   Tiszlavicz, L ^b   Lazar G ^b   Duda, E ^c   Szentpali K ^a   Czako L ^b   Boros, M ^a   Balogh, A ^a   Lazar Jr G ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c INSTITUTE OF BIOCHEMISTRY   (Hungary)

Author keywords

Experimental pancreatitis; Glucocorticoid hormones; Leukocytes; Organ failure; Tissue adenosine triphosphate

Indexed keywords

ADENOSINE TRIPHOSPHATE; DEXAMETHASONE; GLUCOCORTICOID; MIFEPRISTONE; MYELOPEROXIDASE; TAUROCHOLIC ACID;

ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; BODY WEIGHT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; HISTOPATHOLOGY; HORMONE ACTION; LEUKOCYTE; LIVER INJURY; LUNG INJURY; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL RATE;

ACUTE DISEASE; ADENOSINE TRIPHOSPHATE; AMYLASES; ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; DEXAMETHASONE; HYDROCORTISONE; INTERLEUKIN-6; LIVER; LUNG; MALE; MIFEPRISTONE; MULTIPLE ORGAN FAILURE; NEUTROPHILS; PANCREAS; PANCREATITIS; PEROXIDASE; PREMEDICATION; RATS; RATS, WISTAR; TAUROCHOLIC ACID;

EID: 3042737167     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200407000-00059     Document Type: Article

References (38)

1. Gloor B, Reber HA. Effects of cytokines and other inflammatory mediators on human acute pancreatitis. J Intensive Care Med. 1998;13:305-312.
2. Osman MO, Jensen SL. Acute pancreatitis: the pathophysiological role of cytokines and integrins. Dig Surg. 1999;16:347-362.
3. Norman JG. New approaches to acute pancreatitis: role of inflammatory mediators. Digestion. 1999;60:57-60.
4. Heath DI, Cruickshank A, Gudgeon M, et al. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut. 1993;34:41-45.
5. Leser HG, Gross V, Scheibenbogen C, et al. Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology. 1991;101:782-785.
6. Beutler B, Krochin N, Milsark IW, et al. Control of cachectin (tumor necrosis factor) synthesis: mechanism of endotoxin resistance. Science. 1986;232:977-980.
7. Zanker B, Walz G, Wieder KJ, et al. Evidence that glucocorticoids block expression of the human interleukin-6 gene by accessory cells. Transplantation. 1990;49:183-185.
8. Radomski MW, Palmer RMJ, Moncada S. Glucocorticoids inhibit the expression on inductive, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA. 1990;87:10043-10047.
9. Hammerschmidt DE, White JG, Craddock PR, et al. Corticosteroids inhibit complement-induced granulocyte aggregation: a possible mechanism for their efficacy in shock states. J Clin Invest. 1979;63:798-803.
10. Zuckerman SH, Shellhaas J, Butler LD. Differential regulation of lipopolysaccharide-induced interleukin-1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis. Eur J Immunol. 1989;19:301-305.
11. Reishi A, Tooru S, Kenji K, et al. The role of endogenous glucocorticoids in rat experimental models of acute pancreatitis. Gastroenterology. 1995;109:933-943.
12. Kimura K, Shimosegawa T, Sasano H, et al. Endogenous glucocorticoids decrease the acinar cell sensitivity to apoptosis during cerulein pancreatitis in rats. Gastroenterology. 1998;14:372-381.
13. Joachim M, Stephan B, Wolfgang F. Role of glucocorticosteroids in the regulation of pancreatic amylase synthesis. Pancreas. 1989;4:194-203.
14. Pescador R, Manso MA, Rebollo AJ, et al. Effect of chronic administration of hydrocortisone on the induction and evolution of acute pancreatitis induced by cerulein. Pancreas. 1995;11:165-172.
15. Gloor B, Uhl W, Tcholakov O, et al. Hydrocortisone treatment of early SIRS in acute experimental pancreatitis. Dig Dis Sci. 2001;46:2154-2161.
16. Bone RC, Fischer CJ, Clemmer TP, et al. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med. 1997;317:653-658.
17. Van Rooijen N, Van Nieuwmegen R. Elimination of phagocytic cells in the spleen after intravenous injection of liposome-encapsulated dichloromethylene diphosphonate. An enzyme-histochemical study. Cell Tissue Res. 1984;238:355-358.
18. Ceska M, Birath K, Brown B. A new and rapid method for the clinical determination of amylase activities in human serum and urine. Clin Chem Acta. 1969;26:437-444.
19. Aarben LA, De Groot ER, Schaap OL, et al. Production of hybridoma growth factor by human monocytes. Eur J Immunol. 1987;17:1411-1416.
20. Kuebler WM, Abels C, Schuerer L, et al. Measurement of neutrophil content in brain and lung tissue by a modified myeloperoxidase assays. Int J Microcirc Clin Exp. 1996;16:89-97.
21. Lamprech W, Trautschold I. Adenosine 5′-triphosphate determination with hexokinase and glucose 6-phosphate dehydrogenase. In: Bergmeyer HU, ed. Methods of enzymatic analysis. New York: Verlag Chemie, Weinheim and Academic Press; 1976:4:2101-2109.
22. Christopher BH, Hani P, Grewal L, et al. Anti-TNF-α therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat. Am J Surg. 1996;71:274-280.
23. Abe R, Shimosegawa T, Kikuchi Y, et al. The role of pituitary-adrenal counterregulation of inflammation in cerulein-induced pancreatitis: A comparison between Fischer and Lewis rats. Pancreas. 1996;12:280-285.
24. De Dios I, San Roman JI, Manso M, et al. Glucocorticoids effects on exocrine pancreatic secretion in cerulein-induced acute pancreatitis in the rat. Arch Int Physiol Biochim. 1990;98:361-369.
25. Manso MA, Rebollo A, Pescador R, et al. Action of CCK on CDE diet-induced acute pancreatitis in rats treated with hydrocortisone. Comp Biochem Phys C Pharm Tox Endocr. 1995;111:257-263.
26. Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg. 1998;175:76-83.
27. Tcholakov O, Uhl W, Gloor B, et al. Role of arachidonic acid metabolism and its inhibition by hydrocortisone in experimental acute pancreatitis. Eur Surg Res. 1999;31:79-80.
28. Osman MO, Jacobsen NO, Kristensen J, et al. Beneficial effects of hydrocortisone in a model of experimental acute pancreatitis. Dig Surg. 1999;16:214-221.
29. Adcock IM, Shirasaki H, Gelder CM, et al. The effect of glucocorticoids on phorbol ester and cytokine stimulated transcription factor activation in human lung. Life Sci. 1994;55:1147-1153.
30. Scheinman RI, Gualbert A, Jewell CM, et al. Characterization of mechanism involved in transrepression of NF-κB by activated glucocorticoid receptors. Mol Cell Biol. 1995;15:943-953.
31. Barnes PJ, Karin M. Mechanism of disease: Nuclear factor-κB-a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997;15:1066-1071.
32. Hans-Ulrich S, Hans H, Thomas S, et al. Randomized, placebo-controlled trial of lazaroid effects on severe acute pancreatitis in rats. Crit Care Med. 2001;29:861-869.
33. Marco S, Michael AD, Hans GB. Different changes in high-energy phosphates in alcoholic acute pancreatitis and taurocholate acute pancreatitis in rats using NMR spectroscopy at 2.0 T. Pancreas. 1997;15:350-357.
34. Halangk W, Matthias R, Nedelev B, et al. Energy metabolism of pancreatic mitochondria in experimental acute pancreatitis. Zentralbl Chir. 1997;122:305-308.
35. Yan L, Kazue O, Nobuaki K. Changes hepatic energy metabolism in experimental acute pancreatitis. Chin Med J. 1992;105:684-688.
36. Takashi U, Hung SH, Steven EA, et al. Pancreatitis-induced ascitic fluid and hepatocellular dysfunction in severe acute pancreatitis. J Surg Res. 1999;82:305-311.
37. Lazar G Jr, Varga J, Lazar G, et al. The effects of glucocorticoids and a glucocorticoid antagonist (Ru-38486) on experimental acute pancreatitis in rat. Acta Chir Hung. 1997;36:190-191.
38. Lazar G Jr, Duda E, Lazar G. Effect of RU-38486 on TNF production and toxicity. FEBS Lett. 1992;308:137-140.